SMC18 treatment significantly increased the infiltration of CD8+ T cells (Fig. 5C, Fig. S5B ~ C) and the amount of CD8+ T cell secreting IFN-γ (Fig. 5D) in the tumor tissue. The gene discussed is CD8A; the disease is neoplasm.